Real-world treatment patterns and outcomes for patients with non-metastatic non-small cell lung cancer: retrospective analyses in Canada, England, and Germany
These data provide insights into treatment pathways and survival outcomes before the widespread use of immunotherapy-based and targeted therapies and will serve as an important baseline for future evaluations of emerging treatments for patients with non-metastatic NSCLC.
Authors
- Minouk J. Schoemaker (ORCID: https://orcid.org/0000-0001-8403-2234)
- C. Rault (ORCID: https://orcid.org/0000-0001-9719-0653)
- Alastair Greystoke (ORCID: https://orcid.org/0000-0001-9168-0387)
- Stefano Lucherini (ORCID: https://orcid.org/0000-0001-6410-6865)
- Winson Y. Cheung (ORCID: https://orcid.org/0000-0002-3679-4290)
- Gabrielle Emanuel
- M. Daumont (ORCID: https://orcid.org/0000-0002-4319-1498)
- Cátia Leal (ORCID: https://orcid.org/0000-0003-0820-7690)
- Alexander Katalinic (ORCID: https://orcid.org/0000-0003-0490-1554)
- Hannah Baltus (ORCID: https://orcid.org/0009-0003-0230-4163)
- Philip Q. Ding (ORCID: https://orcid.org/0000-0002-0413-5485)
- Eleanor Ralphs (ORCID: https://orcid.org/0000-0001-7986-8205)
- Annika Waldmann (ORCID: https://orcid.org/0000-0002-5909-9936)
- Lien Vo
- Valeria M. Saglimbene
Institutions
- University of Calgary (CA)
- IQVIA (United Kingdom) (GB)
- Sir Bobby Robson Foundation (GB)
- Bristol-Myers Squibb (United States) (US)
- Calgary Laboratory Services (CA)
- Bristol-Myers Squibb (United Kingdom) (GB)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Bristol-Myers Squibb (Belgium) (BE)
- IQ Solutions (US)
- Newcastle University (GB)
- University of Lübeck (DE)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1186/s12890-025-03715-9
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00